Endocannabinoid-type compound | Group | Value | Baseline | Week after start of treatment | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 4 | 6 | 8 | 10 | 12 | 14 | 16 | 18 | 20 | ||||
Anandamide | Control | Mean | 4.24 | 4.80 | 5.60 | 4.31 | 4.82 | 4.66 | 6.02 | 6.19 | 2.82 | 5.19 | 5.15 |
SEM | 2.00 | 1.18 | 2.17 | 0.93 | 0.80 | 0.91 | 3.84 | 2.65 | 0.77 | 1.38 | 1.67 | ||
Treated | Mean | 3.07 | 3.40 | 2.86 | 2.98 | 2.86 | 3.34 | 2.28 | 3.64 | 4.25 | 4.05 | 4.44 | |
SEM | 0.52 | 1.54 | 0.93 | 0.56 | 0.92 | 1.35 | 0.97 | 1.35 | 1.69 | 1.53 | 0.43 | ||
2-arachidonoylglycerol | Control | Mean | 14.3 | 21.0 | 23.1 | 21.9 | 27.8 | 20.7 | 28.6 | 22.7 | 19.0 | 18.6 | 22.4 |
SEM | 5.5 | 13.8 | 15.9 | 11.1 | 19.2 | 15.2 | 20.6 | 12.3 | 11.8 | 11.3 | 15.5 | ||
Treated | Mean | 16.8 | 19.2 | 13.3 | 9.14 | 11.7 | 4.42 | 8.48 | 15.0 | 26.5 | 16.5 | 26.4 | |
SEM | 6.4 | 9.2 | 7.9 | 1.12 | 3.3 | 1.60 | 4.20 | 10.0 | 19.1 | 9.1 | 11.3 | ||
EPA ethanolamide | Control | Mean | 1.36 | 1.45 | 0.91 | 1.25 | 0.22 | 0.57 | 1.00 | 1.07 | 2.07 | 2.04 | 2.84 |
SEM | 0.49 | 0.29 | 0.16 | 0.31 | 0.07 | 0.20 | 0.07 | 0.71 | 0.84 | 0.62 | 1.06 | ||
Treated | Mean | 0.47 | 1.04 | 1.05 | 1.13 | 0.85 | 1.00 | 1.07 | 0.58 | 1.34 | 1.55 | 0.63 | |
SEM | 0.13 | 0.48 | 0.34 | 0.26 | 0.24 | 0.17 | 0.26 | 0.22 | 0.93 | 0.51 | 0.35 | ||
DHA ethanolamide | Control | Mean | 1.23 | 4.67 | 5.17 | 6.64 | 4.95 | 4.63 | 4.61 | 2.28 | 3.89 | 5.82 | 4.80 |
SEM | 0.29 | 1.35 | 2.09 | 1.95 | 2.45 | 2.03 | 2.06 | 1.10 | 1.45 | 2.49 | 1.91 | ||
Treated | Mean | 3.06 | 6.63 | 8.03 | 7.24 | 6.60 | 7.41 | 4.96 | 3.49 | 5.57 | 5.97 | 6.76 | |
SEM | 1.68 | 3.17 | 2.34 | 1.52 | 1.59 | 1.12 | 0.89 | 0.39 | 1.30 | 2.83 | 2.93 | ||
Palmitoyl ethanolamide | Control | Mean | 54.7 | 64.7 | 58.3 | 94.7 | 53.5 | 71.9 | 89.9 | 30.8 | 24.7 | 59.3 | 120 |
SEM | 4.70 | 10.3 | 15.3 | 30.5 | 12.7 | 11.2 | 7.80 | 4.70 | 1.50 | 20.8 | 36.3 | ||
Treated | Mean | 66.2 | 62.5 | 65.6 | 86.1 | 58.6 | 48.4 | 69.1 | 78.8 | 39.5 | 92.0 | 120 | |
SEM | 19.2 | 11.9 | 14.7 | 17.3 | 13.9 | 9.20 | 2.40 | 23.7 | 8.3 | 31.5 | 47.9 | ||
Oleoyl ethanolamide | Control | Mean | 24.2 | 24.3 | 19.0 | 20.3 | 30.5 | 28.5 | 14.0 | 29.1 | 17.6 | 29.3 | 31.0 |
SEM | 4.44 | 1.50 | 2.25 | 2.23 | 1.55 | 2.65 | 1.35 | 5.26 | 4.10 | 4.60 | 2.28 | ||
Treated | Mean | 24.2 | 22.3 | 16.0 | 20.3 | 24.8 | 29.9 | 14.4 | 36.9 | 18.0 | 39.7 | 45.5 | |
SEM | 3.63 | 6.86 | 2.05 | 2.49 | 6.63 | 7.76 | 2.54 | 15.01 | 3.03 | 14.54 | 9.89 | ||
Dose (mg phospholipids/kg bw/day) | 50 | 150 | 450 | 0 | |||||||||
Dose (mg [EPA/DHA]/kg bw/day) | 9.35/5.48 | 28.0/16.4 | 84.1/49.3 | 0/0 |